These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 18563254)

  • 1. Cell-penetrating peptides as delivery vehicles for biology and medicine.
    Stewart KM; Horton KL; Kelley SO
    Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of cell-penetrating peptides for cargo delivery.
    Pooga M; Langel U
    Methods Mol Biol; 2005; 298():77-89. PubMed ID: 16044541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular transduction using cell-penetrating peptides.
    Sawant R; Torchilin V
    Mol Biosyst; 2010 Apr; 6(4):628-40. PubMed ID: 20237640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB; Pereira MP; Kelley SO
    Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A; Eudes F; Shim YS
    IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classes and prediction of cell-penetrating peptides.
    Lindgren M; Langel U
    Methods Mol Biol; 2011; 683():3-19. PubMed ID: 21053118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
    Kilk K; Langel U
    Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
    Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE
    Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
    Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
    ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a tumor-homing cell-penetrating peptide.
    Myrberg H; Zhang L; Mäe M; Langel U
    Bioconjug Chem; 2008 Jan; 19(1):70-5. PubMed ID: 18001077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cell penetration of acid-degradable particles functionalized with cell-penetrating peptides.
    Cohen JL; Almutairi A; Cohen JA; Bernstein M; Brody SL; Schuster DP; Fréchet JM
    Bioconjug Chem; 2008 Apr; 19(4):876-81. PubMed ID: 18318462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsically cell-permeable miniature proteins based on a minimal cationic PPII motif.
    Daniels DS; Schepartz A
    J Am Chem Soc; 2007 Nov; 129(47):14578-9. PubMed ID: 17983240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
    Kanwar JR; Gibbons J; Verma AK; Kanwar RK
    Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis of oligonucleotide conjugates useful for delivery and targeting of potential nucleic acid therapeutics.
    Lönnberg H
    Bioconjug Chem; 2009 Jun; 20(6):1065-94. PubMed ID: 19175328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemically modified cell-penetrating peptides for the delivery of nucleic acids.
    Mäe M; Andaloussi SE; Lehto T; Langel U
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1195-205. PubMed ID: 19831582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acyl moieties: improving Pro-rich peptide uptake inside HeLa cells.
    Fernández-Carneado J; Kogan MJ; Van Mau N; Pujals S; López-Iglesias C; Heitz F; Giralt E
    J Pept Res; 2005 Jun; 65(6):580-90. PubMed ID: 15885117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The engineering of membrane-permeable peptides.
    Carrigan CN; Imperiali B
    Anal Biochem; 2005 Jun; 341(2):290-8. PubMed ID: 15907875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.
    Juliano RL; Alam R; Dixit V; Kang HM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):324-35. PubMed ID: 20049800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.